Doha, Qatar: Aspetar, Orthopaedic and Sports Medicine Hospital, has strengthened its Scientific Advisory Board with five prominent international experts, in a step that reflects the hospital’s commitment to advancing its scientific and medical ecosystem and drawing on world-class expertise in sports medicine, orthopaedic surgery, sports rehabilitation, performance science and the care of elite athletes.
The new board members are Dr. Neal El Attrache, Dr. Carly Day, Prof. Andrew M. Jones, Dr. Mathieu Lacome and Daniel Lewindon, bringing together diverse expertise ranging from surgery and athlete medical care to performance science, analytics and applied physiology.
The Scientific Advisory Board will provide independent scientific advice and recommendations in support of Aspetar’s clinical services, scientific research, medical education and strategic development, helping the hospital continue to apply global standards and enhance the quality of care provided to athletes.
Commenting on the announcement, Acting Director General of Aspetar Khalid Ali Al Mawlawi said: “The formation of the Scientific Advisory Board with this distinguished group of international experts represents an important milestone in Aspetar’s journey to uphold the highest standards of medical and scientific excellence. We are not simply attracting world-renowned names; we are bringing together diverse expertise from medicine, surgery, scientific research and performance science around a shared vision: advancing the care of athletes and translating scientific knowledge into practices with real impact. We look forward to the board’s independent recommendations and expertise supporting innovation, developing our services and scientific programmes, and reinforcing Aspetar’s position as a global reference in sports medicine and sports science.”
The board derives strength from the breadth of its members’ experience and their practice at some of the world’s leading sporting and academic institutions. This expertise offers Aspetar an independent international perspective that supports medical and scientific innovation, closely links research to the needs of athletes and high-performance environments, and affirms Aspetar’s scientific leadership in sports medicine.